Clinton, Missouri-based Golden Valley Memorial Healthcare is the first to deploy Meditech's solution, Expanse Genomics. It allows providers to analyze and parse genetic results into actionable data that is displayed directly in patient charts, according to Meditech.
All the hype around precision medicine can make it seem intimidating and foreign. The good news is that it does not represent a departure from current clinical practice, and it can significantly improve patient care.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Lilly Institute for Genetic Medicine is a new facility in Boston that will focus on the R&D of RNA and DNA-based therapies. Eli Lilly is investing about $700 million to establish the site, which will also include lab and office space for biotech startups.
Healthcare consumers are increasingly aware of specific therapies in development or on the market that can help treat the diseases they or their loved ones may be suffering from — and this growing awareness is changing the precision medicine arena.
The Chicago-based startup company plans to use the funding to further growth of its product offering and integration with EHRs and genetic testing partners.
The new report, from the University of Pittsburgh Medical Center's Center for Connected Medicine, surveyed 101 representatives of hospitals and healthcare systems. Nine out of 10 respondents said they were providing genomic or genetic testing or planning to.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Boston-based drugmaker Vertex Pharmaceuticals leads the round and also enters partnership with UK firm to aid its own drug development efforts.
Mount Sinai Health System's new spinout company, Sema4, will rely on genomic and clinical data to better diagnose, treat and prevent diseases.
Harvard Medical School is giving students of all stripes a way to learn about medicine and healthcare through its HMX Fundamentals program.
CEO Arthur Tzianabos characterized the funding as “a huge leap forward for a new way to gene-edit for patients suffering with rare disorders.”
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
It's unclear whether the information the tests provide make any difference in a patient’s treatment and prognosis.
Genetic testing can play a critical role in helping potential parents understand their options if they are carriers for a wide array of genetic disorders, such as cystic fibrosis.
Researchers at the hospital's Manton Center for Orphan Disease Research will train Watson in nephrology by reading medical literature and scanning data on mutations for a kidney disease known as steroid-resistant nephrotic syndrome.
Researchers now have many more resources to explore genetic variations.
The Genetic Portrait Project's aim is to chronicle society's view of genetic research. Photographer Stefan Petranek uses genetic conferences to reach out to industry professionals - asking them what they think is the future of genetic research.